Overview Evaluate the Efficacy and Safety of DWJ1506 and DWJ1507 Status: Not yet recruiting Trial end date: 2022-12-01 Target enrollment: Participant gender: Summary The purpose of this study is to determine the efficacy and safety of DWJ1506 and DWJ1507 in the patients with dyslipidemia. Phase: Phase 3 Details Lead Sponsor: Daewoong Pharmaceutical Co. LTD.